Company intelligence / Profile preview
Trio Medicines Ltd
London, England, United Kingdomtriomedicines.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Phase 3
01
Overview
Trio Medicines Ltd develops science-based medicines for unmet medical needs, focusing on small molecule antagonists of the gastrin/CCK2 and related receptors. Its lead asset netazepide reached clinical development but was discontinued. Other assets include ceclazepide (pending), TR4 for asthma/inflammation (Phase 2), and TR8 for inflammation (preclinical). The company has also been involved with protein drugs such as interferon beta. No current active clinical trials are registered.
- Therapeutic areas
- GastroenterologyPulmonologyCardiovascularImmunologyOncologyNeurology
- Modalities
- Small molecules (notably CCK2/gastrin receptor antagonists)Protein drugs (e.g., interferon beta, per external pipeline data)[9]
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
None publicly disclosed beyond parent company support; seeking partners for pivotal studies.[1]
Beyond the preview
Go deeper on Trio Medicines Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trio Medicines Ltd.